交易中 07-18 11:38:27 美东时间
-0.350
-0.64%
https://www.bloomberg.com/news/articles/2025-07-11/us-india-in-talks-on-trade-deal-that-may-cut-tariff-below-20
07-12 02:06
U.S. President Donald Trump hinted that he is close to reaching a deal with India after announcing new reciprocal tariffs on 14 countries, including Japan and South Korea, among others. However, as ...
07-10 14:51
https://www.youtube.com/watch?v=czuxZsbndVk
07-02 03:02
https://asia.nikkei.com/Economy/Trade-war/Trump-tariffs/US-to-handle-Japan-later-in-tariff-talks-prioritizing-India
07-02 02:22
Trump's tariff threats have caused uncertainty, but ETF investors are staying calm for now. Nation-specific ETFs and safe havens are popular choices.
07-01 03:56
T. Rowe Price debuts two new actively managed ETFs: TGLB and TIER, offering investors a chance to diversify and benefit from active management.
06-27 23:19
Indaptus Therapeutics董事会批准了1:28的反向股票分割,将于6月26日生效,交易调整于6月27日开始。股票代码保持不变,CUSIP变更为45339J 204。此次操作旨在提升股价以符合纳斯达克要求并吸引更多投资者。股东将不会收到零散股,零散股将获得现金补偿。股票数量将由1600万股减至57.2万股,托管股证持有者将自动处理。
06-25 11:00
https://www.bloomberg.com/news/articles/2025-06-23/india-us-eye-trade-deal-by-july-though-challenges-remain?embedded-checkout=true
06-23 22:35
Indaptus Therapeutics announced the sale of approximately $2.3 million in convertible promissory notes and warrants, with plans to raise up to $5 million. The notes bear 6% interest annually, mature in July 2026, and convert into shares at 80% of the average closing price over five days prior to conversion, capped at $0.40. Warrants for 200% of the conversion shares will be issued post-conversion. Proceeds will fund research, including a Phase 1b...
06-13 12:00
https://www.bloomberg.com/news/articles/2025-06-10/india-us-to-expedite-trade-talks-targeting-early-wins?embedded-checkout=true
06-10 23:58